ERBB2 and cancer: These antibody-drug conjugates exhibited clear antigen-dependent cytotoxicity on a panel of cancer cell lines, induced AS of CDKN1B; and inhibited tumor growth in a Her2-positive gastric cancer xenograft mouse model [312].